This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Implicit parasitic Sepsis
AB1_SEPSIS_PARAS_IMPL
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditions
|
56330 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
163 |
4. Check minimum number of eventsNone |
163 |
5. Include endpointsNone |
163 |
6. Filter based on genotype QC (FinnGen only) |
163 |
Control definitions (FinnGen only)
- Control exclude
- AB1_SEPSIS_EXPLICIT, AB1_SEPSIS_IMPLICIT
Extra metadata
- First used in FinnGen datafreeze
- DF8
Similar endpoints
↥List of similar endpoints to
Implicit parasitic Sepsis
based on the number of shared cases.
Similar with more cases:
- Implicit Sepsis
- Condition for Implicit Sepsis (Organ dysfunction codes)
- Certain infectious and parasitic diseases
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 163 | 91 | 72 |
| Unadjusted period prevalence (%) | 0.03 | 0.03 | 0.03 |
| Median age at first event (years) | 53.25 | 50.84 | 56.28 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 151
- Matched controls
- 1510
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
R55
ICD-10 Finland
Syncope and collapse
39.0
58.2
75
37
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
8.2
23.2
58
106
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
14.5
21.5
37
33
A06.9
ICD-10 Finland
Amoebiasis, unspecified
+∞
18.1
17
*
A07.8
ICD-10 Finland
Other specified protozoal intestinal diseases
+∞
15.9
15
*
A07.1
ICD-10 Finland
Giardiasis [lambliasis]
+∞
15.9
15
*
J01MA12
ATC
levofloxacin; systemic
5.8
15.9
50
118
P01AB01
ATC
metronidazole; oral, rectal
4.1
14.9
87
379
N17.9
ICD-10 Finland
Acute renal failure, unspecified
59.2
14.1
16
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
4.2
14.1
67
240
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.9
14.0
91
425
C03CA01
ATC
furosemide; systemic
4.1
13.5
65
233
AA1AD
NOMESCO Finland
CT of head and brain
4.3
13.2
59
197
A07.9
ICD-10 Finland
Protozoal intestinal disease, unspecified
141.2
12.6
13
*
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
5.5
12.6
40
93
R06.0
ICD-10 Finland
Dyspnoea
3.8
11.9
61
226
TPH04
NOMESCO Finland
Cathetrisation of vein
4.1
11.2
50
163
XF400
NOMESCO Finland
ECG with 12 standard connections
4.2
10.8
45
138
J18.9
ICD-10 Finland
Pneumonia, unspecified
3.6
10.1
53
196
H02AB06
ATC
prednisolone; systemic
3.0
9.7
87
469
A06.0
ICD-10 Finland
Acute amoebic dysentery
106.4
9.5
10
*
R51.80
ICD-10 Finland
Headache
4.2
9.5
38
111
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
3.9
9.2
41
132
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
9.6
9.1
18
21
R50.9
ICD-10 Finland
Fever, unspecified
4.1
8.9
36
106
R11
ICD-10 Finland
Nausea and vomiting
6.0
8.8
24
46
C07AB07
ATC
bisoprolol; oral
2.9
8.8
84
461
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
6.3
8.7
23
42
A02BC01
ATC
omeprazole; systemic
3.1
8.6
56
240
A41.9
ICD-10 Finland
Sepsis, unspecified
+∞
8.4
8
*
A10AE04
ATC
insulin glargine; parenteral
5.3
8.3
25
54
E0000UV
ATC
NA
2.8
8.1
75
397
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
3.2
8.0
47
185
L28
ICPC
Limited function/disability (L)
3.9
8.0
34
104
J01MA02
ATC
ciprofloxacin; systemic
2.8
8.0
69
349
E86
ICD-10 Finland
Volume depletion
16.1
7.9
12
8
R53
ICD-10 Finland
Malaise and fatigue
3.3
7.8
43
162
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
3.5
7.8
39
137
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
3.7
7.7
36
119
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
5.3
7.7
23
49
FPE20
NOMESCO Finland
Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes
7.8
7.7
17
24
N05CF01
ATC
zopiclone; oral
2.8
7.7
62
299
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
4.5
7.7
27
69
A06AD11
ATC
lactulose; oral
4.2
7.6
29
80
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
4.1
7.6
30
86
A49.9
ICD-10 Finland
Bacterial infection, unspecified
5.0
7.6
24
55
SPAT1262
SPAT
Handing over of treatment supplies
3.5
7.5
37
128
D64.9
ICD-10 Finland
Anaemia, unspecified
4.7
7.4
25
61
A02BC03
ATC
lansoprazole; oral
2.8
7.4
59
282
103
Kela drug reimbursment
Diabetes, insulin-treated
2.9
7.4
52
229
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.7
7.4
34
111
N30.0
ICD-10 Finland
Acute cystitis
4.0
7.3
30
89
N05BA01
ATC
diazepam; systemic, rectal
3.7
7.1
32
103
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
8.2
7.1
15
20
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.6
7.1
65
337
J01FF01
ATC
clindamycin; systemic
2.8
7.1
53
244
S06.0
ICD-10 Finland
Concussion
4.3
7.0
26
70
N05AH04
ATC
quetiapine; oral
3.5
7.0
34
116
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
4.1
7.0
27
76
A28
ICPC
Limited function/disability NOS
3.5
6.9
33
111
K92.1
ICD-10 Finland
Melaena
7.8
6.9
15
21
Z95.0
ICD-10 Finland
Presence of electronic cardiac devices
6.0
6.9
18
33
J96.1
ICD-10 Finland
Chronic respiratory failure
42.0
6.8
8
*
WX002
NOMESCO Finland
Sedation and analgesia
3.0
6.8
43
175
UJF32
NOMESCO Finland
Coloscopy
2.7
6.7
53
248
C10AA05
ATC
atorvastatin; oral
2.5
6.7
68
369
J01MA06
ATC
norfloxacin; oral
3.4
6.6
33
115
XF404
NOMESCO Finland
Ambulatory ECG
4.3
6.6
24
64
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
4.8
6.6
21
49
R5140
NOMESCO Finland
Monitoring the use of the aid
4.1
6.5
25
70
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
15.2
6.5
10
7
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
3.0
6.5
42
174
JN4AD
NOMESCO Finland
Body CT examination
4.7
6.4
21
50
M01AE02
ATC
naproxen; oral, rectal
2.4
6.4
93
602
R06AE07
ATC
cetirizine; oral
2.5
6.4
72
409
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.5
6.4
30
100
N03AX09
ATC
lamotrigine; oral
6.3
6.3
16
28
H32.0*B58.0
ICD-10 Finland
Toxoplasma chorioretinitis
+∞
6.3
6
*
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
+∞
6.3
6
*
R40.2
ICD-10 Finland
Coma, unspecified
+∞
6.3
6
*
1369X
ICD-9 Finland
Other and unspecified infectious and parasitic diseases, Unspecified infectious and parasitic diseases
+∞
6.3
6
*
B58.9
ICD-10 Finland
Toxoplasmosis, unspecified
+∞
6.3
6
*
B50.9
ICD-10 Finland
Plasmodium falciparum malaria, unspecified
+∞
6.3
6
*
B01AA03
ATC
warfarin; systemic
2.9
6.3
41
171
R07.4
ICD-10 Finland
Chest pain, unspecified
2.6
6.2
51
245
A04
ICPC
Weakness/tiredness general
3.3
6.2
31
108
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.9
6.2
41
173
H04AA01
ATC
glucagon; nasal, parenteral
9.2
6.2
12
14
R4110
NOMESCO Finland
Physiotherapy
2.6
6.2
52
250
I44.2
ICD-10 Finland
Atrioventricular block, complete
13.3
6.2
10
8
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
4.2
6.0
22
59
ZXE10
NOMESCO Finland
More than one and less than three hours
2.4
6.0
67
376
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3003327) Ova and parasites identified in Stool by Light microscopy
32
36
10.82
26.88
3.4
1.5
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
27
40
7.89
18.02
1.4
1.6
ug/l
1.2
8.1
0.46
21
34
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
35
75
5.67
16.30
2.3
1.6
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
55
175
4.23
15.81
3.1
1.7
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
91
417
3.68
15.19
10.8
5.4
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
74
299
3.70
14.95
8.0
3.7
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
50
159
4.09
14.24
3.1
2.1
g/l
2.2
2.3
0.87
45
141
(3044290) Cell count panel - Cerebral spinal fluid
17
19
9.87
14.03
1.1
2.7
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
39
105
4.57
13.80
6.2
4.3
mmol/l
1.2
2.1
0.80
32
83
(36304419) Bacteria [Presence] in Urine
78
343
3.44
13.54
4.2
2.6
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
107
575
3.51
13.29
10.6
5.6
%
0.6
0.7
0.16
98
536
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
47
151
3.97
13.10
3.3
2.1
%
18.4
23.4
1.49
40
134
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
91
448
3.33
12.98
5.0
2.8
—
—
—
0
0
(3000991) Gas panel - Venous blood
35
91
4.62
12.89
14.5
5.7
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
83
390
3.30
12.75
4.8
2.8
e6/l
24.3
77.9
1.30
62
292
(3022948) Iron [Moles/volume] in Serum or Plasma
52
183
3.70
12.66
3.1
2.1
umol/l
10.5
14.0
1.92
46
161
(3003396) Base excess in Arterial blood by calculation
40
118
4.17
12.49
13.5
4.9
mmol/l
1.2
1.1
0.04
34
93
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
40
118
4.17
12.49
2.9
1.6
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
102
546
3.32
12.49
7.7
3.8
g/l
33.9
36.2
3.44
97
512
(3012544) pH of Venous blood
39
113
4.22
12.47
6.2
4.2
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
56
209
3.56
12.45
3.8
3.3
ng/l
615.7
195.2
0.71
46
161
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
40
119
4.13
12.34
2.8
1.6
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
109
611
3.37
12.26
14.6
5.3
mmol/l
1.2
1.2
1.92
96
508
(3006504) Eosinophils/100 leukocytes in Blood
107
594
3.33
12.22
10.8
5.6
%
2.8
2.7
0.08
98
553
(3013826) Glucose [Moles/volume] in Serum or Plasma
124
753
3.70
12.20
10.0
3.9
mmol/l
6.9
6.6
0.53
118
689
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
15
17
9.62
12.19
2.2
1.7
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
13
12
11.69
12.11
1.8
1.4
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
16
20
8.76
12.10
2.3
1.6
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
16
20
8.76
12.10
2.4
1.7
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
31
77
4.74
12.03
10.5
5.7
mmol/l
25.5
24.8
0.68
31
77
(3019069) Monocytes/100 leukocytes in Blood
107
599
3.29
11.95
11.1
5.8
%
8.9
8.5
0.65
98
565
(3030467) Casts [#/volume] in Urine by Automated count
76
351
3.18
11.82
4.9
2.7
e6/l
0.3
0.3
0.14
55
251
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
12
11
11.70
11.19
2.3
1.5
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
107
615
3.15
11.12
10.9
5.6
%
27.0
28.2
0.51
98
577
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
25
56
5.09
10.91
16.0
5.3
mmol/l
24.9
24.6
0.19
25
50
(3018095) Leukocytes [#/volume] in Urine
88
461
2.98
10.68
5.8
3.2
e6/l
44.3
49.8
0.08
62
318
(3001604) Monocytes [#/volume] in Blood
108
637
3.06
10.47
10.6
5.6
e9/l
0.6
0.6
0.37
93
561
(3026782) Osmolality of Urine
58
243
3.15
10.46
4.1
2.4
mosm/kgh2o
483.5
578.8
2.72
45
204
(3006315) Basophils [#/volume] in Blood
108
638
3.05
10.43
10.6
5.6
e9/l
0.0
0.0
0.24
93
560
(3018010) Neutrophils/100 leukocytes in Blood
104
609
2.96
10.07
10.3
5.5
%
57.8
57.2
0.25
96
573
(3019198) Lymphocytes [#/volume] in Blood
109
655
3.00
10.06
10.7
5.6
e9/l
1.8
1.9
0.61
95
591
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
62
276
3.01
9.99
2.5
2.0
mg/l
1.4
1.0
0.48
52
216
(3013115) Eosinophils [#/volume] in Blood
109
660
2.97
9.82
11.5
5.8
e9/l
0.2
0.2
0.45
96
590
(3000850) Epithelial cells [#/volume] in Urine
59
262
2.96
9.48
3.4
2.4
e6/l
5.3
5.4
0.02
49
231
(3009445) Proteinase 3 Ab [Units/volume] in Serum
21
47
4.98
9.13
1.1
1.4
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
116
753
2.87
8.70
14.1
9.5
e9/l
4.3
4.0
0.49
103
669
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
14
22
6.87
8.68
2.1
1.9
—
—
—
0
0
(3009343) pH of Capillary blood
29
88
3.79
8.55
4.1
2.2
ph
7.4
7.4
—
6
9
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
15
26
6.25
8.49
3.9
2.0
u/ml
0.4
0.4
—
8
13
(3026008) Bacteria identified in Urine by Culture
73
381
2.66
8.44
3.5
2.8
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
20
46
4.82
8.41
12.3
5.6
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
28
84
3.82
8.38
4.2
2.3
mmol/l
1.7
1.9
0.07
22
63
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
36
128
3.33
8.35
3.2
2.9
umol/l
6.3
7.7
0.51
30
110
(3037522) Nuclear Ab [Titer] in Serum
41
158
3.13
8.34
1.4
1.3
titre
448.0
524.9
—
10
41
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
23
60
4.30
8.30
2.3
1.7
—
—
—
0
0
(3018418) pH of Serum or Plasma
73
385
2.62
8.21
6.1
3.4
ph
7.4
7.4
0.15
15
83
(3037467) Urinalysis macro (dipstick) panel - Urine
128
890
3.04
8.17
8.3
3.8
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
88
510
2.58
8.11
2.6
1.9
pmol/l
104.3
91.9
1.51
53
243
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
11
14
8.35
8.09
1.9
1.5
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
26
77
3.83
7.91
1.8
1.7
g/l
1.2
1.3
0.12
26
69
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
70
368
2.58
7.86
4.4
3.1
ng/l
1381.4
1462.6
0.09
61
302
(3002179) Metamyelocytes/100 leukocytes in Blood
28
88
3.63
7.83
4.9
4.7
%
0.3
0.6
0.59
12
19
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
47
206
2.80
7.53
4.3
2.4
e6/l
3.5
0.9
0.42
24
115
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
137
1008
3.25
7.52
13.7
6.6
u/l
75.4
79.0
0.67
132
932
(3026493) Urate [Moles/volume] in Serum or Plasma
62
313
2.58
7.51
4.8
2.8
umol/l
352.7
5064.4
1.23
53
268
(3025941) Bacteria identified in Stool by Culture
26
80
3.68
7.48
1.7
1.2
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
44
188
2.84
7.38
4.5
2.6
e6/l
4.8
2.0
0.45
21
99
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
21
56
4.16
7.35
3.0
2.0
g/l
1.6
1.5
0.26
21
45
(3021879) Hepatitis B virus core Ab [Presence] in Serum
26
81
3.63
7.35
1.8
1.5
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
28
94
3.39
7.06
4.5
2.7
e9/l
58.9
73.2
1.84
19
73
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
73
408
2.43
7.02
3.9
2.1
u/l
54.0
57.3
0.43
65
371
(3019060) Gas panel - Arterial blood
24
74
3.63
6.87
5.0
2.7
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
14
28
5.38
6.84
1.1
1.2
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
10
14
7.54
6.77
1.0
3.2
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
16
37
4.69
6.66
1.4
1.3
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
89
553
2.34
6.62
4.3
2.7
ug/l
121.5
106.9
0.31
83
500
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
85
519
2.33
6.57
3.0
2.2
nmol/l
73.5
76.1
0.46
78
448
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
59
307
2.44
6.56
2.9
1.9
mg/l
2.7
3.0
0.48
54
256
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
83
502
2.33
6.55
5.3
3.9
ng/l
52.1
46.4
0.10
65
345
(3019309) Folate [Moles/volume] in Red Blood Cells
49
234
2.56
6.54
2.0
1.7
nmol/l
875.5
1173.4
1.80
36
169
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
25
82
3.42
6.52
5.2
3.3
ng/l
100.9
85.0
0.42
19
73
(3007164) IgA [Mass/volume] in Serum or Plasma
51
249
2.53
6.50
2.3
1.4
g/l
2.4
2.4
0.01
33
146
(3017181) Myelocytes/100 leukocytes in Blood
28
99
3.21
6.49
5.1
4.5
%
0.4
1.2
1.57
15
32
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
10
7
15.10
6.48
2.4
1.3
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
59
310
2.42
6.40
2.0
1.5
nmol/l
17.8
21.4
1.30
53
248
(40758558) Short blood count panel - Blood
63
341
2.38
6.39
8.8
6.6
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
34
138
2.85
6.20
2.4
1.5
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
11
19
6.14
6.19
1.9
1.5
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
10
8
13.21
6.17
1.0
3.3
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
10
8
13.21
6.17
2.4
1.4
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
16
40
4.33
6.05
3.4
3.7
g/l
0.3
0.2
0.58
11
19
(3021440) Promyelocytes/100 leukocytes in Blood
26
92
3.17
6.01
5.3
4.8
%
0.0
0.1
1.37
14
27
(3004588) Protein electrophoresis panel - Serum or Plasma
23
76
3.36
5.92
2.3
2.2
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
11
20
5.83
5.89
1.4
1.4
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
11
20
5.83
5.89
1.9
1.5
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
74
443
2.23
5.81
4.5
3.1
mmol/l
2.3
2.4
2.00
68
385
(46235355) HIV 1 and 2 tests - Meaningful Use set
44
215
2.43
5.51
2.8
1.9
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
21
69
3.35
5.45
1.9
1.2
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
32
135
2.71
5.40
2.4
1.5
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
39
182
2.50
5.37
1.3
1.2
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
28
111
2.84
5.30
2.1
2.2
ug/l
8.9
6.1
0.43
23
96
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
14
35
4.28
5.29
3.5
2.2
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
33
144
2.62
5.21
2.2
1.4
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
25
95
2.93
5.10
1.3
1.1
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
9
9
10.50
5.09
1.9
1.2
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
51
279
2.20
4.86
6.0
3.4
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
10
20
5.26
4.84
1.2
1.2
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
10
20
5.26
4.84
2.0
2.5
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
23
86
2.95
4.82
5.3
5.0
%
0.0
0.0
0.00
12
22
(3048929) Epstein Barr virus Ab [Presence] in Serum
13
33
4.19
4.81
1.3
1.3
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
93
641
2.05
4.78
6.3
3.5
estimate
0.0
0.0
0.00
18
129
(3044640) Blood type and Crossmatch panel - Blood
65
394
2.08
4.74
4.7
2.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
15
43
3.74
4.74
1.6
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
15
43
3.74
4.74
1.6
1.2
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
19
64
3.23
4.73
21.7
5.5
%
0.7
0.7
0.08
19
64
(3032080) INR in Blood by Coagulation assay
76
491
2.03
4.63
15.5
6.3
inr
1.3
1.2
0.31
23
157
(3042936) Bacteria identified in Isolate by Culture
37
180
2.37
4.62
3.6
1.9
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
19
65
3.18
4.62
21.3
5.5
%
1.4
1.5
0.13
19
65
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
7
5
14.53
4.61
1.6
2.0
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
7
5
14.53
4.61
1.6
2.0
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
92
637
2.02
4.61
8.7
4.6
estimate
0.0
0.0
0.00
19
137
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
10
21
5.01
4.59
2.2
1.4
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
32
146
2.48
4.59
1.8
1.7
%
1.7
1.5
0.76
26
121
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
8
8
10.43
4.57
1.5
1.6
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
91
630
2.01
4.54
6.4
3.5
estimate
0.0
0.0
0.00
19
136
(3022313) Gas panel - Capillary blood
19
66
3.13
4.51
3.5
2.2
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
60
359
2.06
4.49
4.4
2.9
mg/l
771.2
58.7
0.51
47
224
(3044889) 12 lead EKG panel
118
902
2.12
4.40
5.5
3.7
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
8
9
9.27
4.33
1.3
1.3
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
124
969
2.17
4.32
6.9
3.8
mm/h
15.3
10.9
1.74
119
875
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
9
13
7.25
4.22
2.7
2.0
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
14
42
3.55
4.15
1.6
1.2
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
14
42
3.55
4.15
3.1
1.8
—
—
—
0
0
(3022145) Colonoscopy Study observation
31
146
2.39
4.14
1.3
1.2
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
8
10
8.34
4.11
1.6
1.6
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
9
14
6.73
4.04
2.7
1.9
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
9
14
6.73
4.04
2.7
1.9
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
9
14
6.73
4.04
2.7
1.9
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
50
290
2.04
4.01
4.4
2.1
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
50
292
2.03
3.93
1.6
1.2
u/ml
1.2
1.4
—
10
75
(3044927) Protein electrophoresis panel - Urine
8
11
7.58
3.90
1.4
1.1
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
9
15
6.28
3.87
2.7
1.9
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
9
15
6.28
3.87
2.7
1.9
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
12
34
3.73
3.84
1.4
1.2
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
6
5
12.38
3.79
1.8
1.0
%
75.0
92.2
—
6
5
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
6
5
12.38
3.79
1.7
2.0
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
6
5
12.38
3.79
1.7
2.0
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
14
45
3.31
3.75
2.6
1.9
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
8
12
6.95
3.72
1.6
1.5
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
8
12
6.95
3.72
2.1
1.6
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
18
68
2.85
3.70
1.3
1.4
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
107
816
1.91
3.69
3.6
3.0
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
151
1312
3.05
3.68
34.1
12.3
mg/l
26.8
21.7
1.07
130
1030
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
34
177
2.16
3.58
2.1
1.5
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
59
376
1.89
3.55
5.6
3.6
mg/mmol
16.4
9.2
0.53
43
224
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
14
47
3.16
3.50
1.2
2.7
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
9
18
5.22
3.42
2.3
4.3
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
7
10
7.25
3.40
1.7
1.6
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
38
211
2.04
3.38
1.1
1.2
iu/ml
31.8
31.4
—
6
65
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
43
250
1.98
3.37
2.1
1.6
pmol/l
436.2
456.8
0.22
38
206
(3021589) Normoblasts [#/volume] in Blood
85
616
1.79
3.33
18.5
9.6
e9/l
0.0
0.0
0.53
68
515
(44806118)
6
7
8.84
3.29
3.3
1.1
—
—
—
0
0
(44790049)
6
7
8.84
3.29
3.3
1.1
—
—
—
0
0
(44790048)
6
7
8.84
3.29
3.3
1.1
—
—
—
0
0
(44790047)
6
7
8.84
3.29
3.3
1.1
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
6
7
8.84
3.29
1.2
1.3
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
6
7
8.84
3.29
1.8
1.3
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
9
19
4.95
3.29
1.8
6.2
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
11
33
3.50
3.25
3.5
4.5
%
206.8
196.7
0.11
11
33
(3008757) Leukocyte morphology finding [Identifier] in Blood
7
11
6.59
3.22
3.6
5.9
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
18
74
2.61
3.17
1.6
1.2
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
16
62
2.75
3.15
2.2
3.5
%
1.0
1.2
0.59
16
62
(3027315) Oxygen [Partial pressure] in Blood
10
29
3.61
3.10
9.3
3.4
kpa
7.8
8.7
—
10
29
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
6
8
7.73
3.08
2.5
1.9
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
9
21
4.47
3.04
1.0
1.0
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
120
980
1.85
3.00
4.6
4.0
pmol/l
15.0
14.8
0.18
109
875
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
5
10.26
3.00
1.4
1.8
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
5
5
10.26
3.00
1.4
1.8
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
5
5
10.26
3.00
1.0
1.0
nmol/l
154.8
153.8
—
5
5
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
17
70
2.59
2.99
1.0
1.0
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
81
592
1.73
2.98
7.1
3.7
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
7
13
5.57
2.90
3.4
2.8
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
25
126
2.16
2.84
2.3
2.0
nmol/l
358.6
367.5
0.09
19
116
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
42
257
1.85
2.80
3.6
2.7
mmol/l
2.4
2.4
1.35
36
230
(3020891) Body temperature
13
48
2.86
2.79
8.5
3.6
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
5
6
8.54
2.77
1.6
2.2
u/l
15.0
11.0
—
5
6
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
5
6
8.54
2.77
3.8
5.2
u/ml
818.2
1113.0
—
5
6
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
5
6
8.54
2.77
1.4
1.7
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
9
24
3.91
2.71
3.4
1.3
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
16
68
2.50
2.65
2.1
2.3
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
136
1174
1.96
2.62
34.3
13.1
%
39.1
39.8
0.47
97
836
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
138
1198
1.99
2.60
6.1
4.6
mu/l
2.0
2.9
0.45
132
1063
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
8
20
4.15
2.60
1.3
1.5
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
8
20
4.15
2.60
1.3
1.5
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
8
20
4.15
2.60
1.9
1.5
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
6
11
5.61
2.56
1.2
1.2
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
53
362
1.69
2.40
1.5
1.5
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
7
17
4.25
2.38
1.3
1.2
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
7
18
4.01
2.28
1.1
1.7
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
9
29
3.22
2.26
2.6
2.4
—
—
—
0
0
(3013290) Carbon dioxide [Partial pressure] in Blood
9
29
3.22
2.26
9.9
3.4
kpa
4.9
5.1
—
9
29
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
5
9
5.69
2.23
1.6
1.8
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
5
9
5.69
2.23
1.6
1.8
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
5
9
5.69
2.23
1.6
1.8
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
6
14
4.41
2.17
4.0
1.8
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
7
20
3.61
2.08
1.1
1.6
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
6
15
4.11
2.06
2.0
1.1
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
148
1346
2.08
2.00
41.0
13.9
mmol/l
138.9
139.7
3.30
148
1303
(3028707) Methadone [Presence] in Urine by Screen method
7
21
3.43
1.99
1.9
1.2
—
—
—
0
0
(1616796) Gas panel - Central venous blood
8
27
3.06
1.96
8.5
2.7
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
5
11
4.65
1.95
1.0
1.2
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
5
11
4.65
1.95
4.6
2.0
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
6
16
3.85
1.95
1.0
1.1
—
—
—
0
0
(3000492) Spirometry study
21
115
1.95
1.94
1.4
1.4
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
148
1350
2.05
1.92
41.4
14.0
mmol/l
4.0
4.0
0.50
148
1306
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
7
22
3.28
1.90
1.3
1.1
—
—
—
0
0
(21494434) Karyotype in Bone marrow
6
17
3.62
1.85
1.5
1.1
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
6
17
3.62
1.85
1.3
1.6
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
6
17
3.62
1.85
1.8
6.2
%
48.6
63.3
—
6
17
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
5
12
4.26
1.83
1.4
1.2
—
—
—
0
0
(3027135) IgG subclass 1 [Mass/volume] in Serum
5
12
4.26
1.83
1.6
1.2
g/l
6.9
6.7
—
5
12
(4062490)
5
12
4.26
1.83
1.6
1.2
—
—
—
0
0
(3028192) IgG subclass 2 [Mass/volume] in Serum
5
12
4.26
1.83
1.6
1.2
g/l
2.2
2.3
—
5
12
(3024139) IgG subclass 3 [Mass/volume] in Serum
5
12
4.26
1.83
1.6
1.2
g/l
0.3
0.3
—
5
12
(3020564) Creatinine [Moles/volume] in Serum or Plasma
150
1379
2.10
1.83
37.4
14.5
umol/l
88.8
76.5
1.56
150
1379
(3029937) Albumin [Presence] in Urine by Test strip
50
360
1.56
1.78
7.0
3.8
estimate
0.0
0.0
0.00
19
131
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
8
30
2.75
1.75
2.1
1.2
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
8
30
2.75
1.75
1.3
1.4
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
5
13
3.93
1.73
3.0
1.8
pg
32.2
31.3
—
5
13
(3013512) EKG study
54
398
1.53
1.72
5.1
3.6
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
125
1100
1.58
1.69
36.8
15.4
%
14.0
13.7
1.90
125
1077
(3016650) Hepatitis A virus Ab [Presence] in Serum
7
25
2.88
1.67
1.1
1.1
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
7
25
2.88
1.67
3.6
1.4
—
—
—
0
0
(40761535) Cells panel - Urine sediment
18
99
1.92
1.65
3.6
3.6
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
7
26
2.77
1.60
2.3
2.2
—
—
—
0
0
(4094501)
7
26
2.77
1.60
1.0
1.1
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
6
20
3.07
1.59
4.5
6.0
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
8
33
2.50
1.56
3.8
2.9
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
8
33
2.50
1.56
1.1
1.1
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
5
15
3.40
1.53
1.4
1.1
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
5
15
3.40
1.53
1.0
1.1
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
5
15
3.40
1.53
3.0
4.6
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
5
15
3.40
1.53
1.4
1.7
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
30
199
1.62
1.49
1.2
1.2
u/ml
1.5
6.8
—
7
85
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
136
1234
1.62
1.47
30.7
12.1
ml/min/173m2
78.3
80.9
0.54
116
990
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
7
28
2.57
1.47
1.1
1.4
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
7
29
2.48
1.41
1.1
1.2
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
9
41
2.26
1.39
2.3
1.3
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
5
17
3.00
1.37
1.0
1.1
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
5
17
3.00
1.37
1.0
1.1
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
9
43
2.16
1.32
2.3
1.3
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
9
43
2.16
1.32
2.3
1.3
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
6
24
2.56
1.31
1.0
1.1
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
6
24
2.56
1.31
1.3
1.9
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
11
55
2.07
1.30
5.1
1.6
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
62
493
1.42
1.30
7.4
3.6
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
9
44
2.11
1.29
2.1
1.8
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
133
1212
1.53
1.28
7.9
5.6
mmol/mol
41.2
39.6
0.92
128
1117
(3017732) Neutrophils [#/volume] in Blood
16
93
1.80
1.26
2.3
2.5
e9/l
3.7
3.9
0.12
11
69
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
8
36
2.28
1.26
9.4
2.0
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
5
19
2.68
1.22
2.6
1.2
nmol/l
0.3
0.4
—
5
12
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
135
1238
1.53
1.22
4.7
3.9
mmol/l
1.3
1.3
0.49
126
1112
(1761868) Lipid panel - Serum or Plasma
36
479
0.68
1.21
4.4
3.0
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
22
143
1.62
1.19
7.0
3.0
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
5
20
2.55
1.16
2.8
2.1
%
86.6
90.1
—
5
20
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
46
355
1.41
1.13
1.9
1.6
mmol/l
1.6
1.4
0.69
38
296
(3019225) pH of Specimen
19
121
1.65
1.11
10.2
3.2
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
8
41
2.00
1.10
1.5
1.8
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
7
33
2.17
1.07
2.6
1.2
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
9
45
2.06
1.07
1.9
1.6
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
46
359
1.39
1.06
5.8
3.3
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
18
116
1.62
1.01
2.9
1.6
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
32
236
1.44
1.00
1.4
1.6
—
—
—
0
0
(4035726)
19
125
1.59
0.99
1.5
1.3
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
140
1310
1.49
0.96
5.9
4.9
mmol/l
2.5
2.7
1.95
132
1189
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
12
70
1.77
0.95
5.4
1.7
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
36
275
1.40
0.93
6.5
3.8
kg/l
1.0
1.0
—
7
35
(40760892) CBC W Ordered Manual Differential panel - Blood
40
313
1.37
0.90
7.4
4.5
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
137
1282
1.43
0.89
5.3
4.4
mmol/l
4.3
4.6
3.75
128
1176
(3027008) Opiates [Presence] in Urine
8
43
1.90
0.89
1.8
1.3
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
14
88
1.65
0.87
1.4
1.2
—
27.2
—
0
7
(3027944) Amphetamines [Presence] in Urine
8
44
1.86
0.87
2.5
1.3
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
8
44
1.86
0.87
1.7
2.6
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
136
1274
1.41
0.85
5.2
4.4
mmol/l
1.4
1.5
1.95
125
1156
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
14
89
1.63
0.84
2.5
3.3
ml/min/173m2
55.4
64.8
—
8
35
(3022621) pH of Urine by Test strip
14
89
1.63
0.84
1.8
2.6
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
19
131
1.51
0.83
3.6
2.1
—
—
—
0
0
(1002224) Polysomnography panel
10
58
1.77
0.81
1.0
1.1
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
0
27
0.00
0.78
0.0
1.4
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
17
117
1.51
0.75
8.1
3.4
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
5
29
1.75
0.64
2.0
1.7
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
5
29
1.75
0.64
1.4
1.1
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
62
543
1.23
0.59
2.2
2.1
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
134
1277
1.28
0.53
5.6
4.4
mmol/l
6.2
5.9
1.36
121
1150
(3024731) MCV [Entitic volume]
151
1464
1.43
0.51
47.5
18.5
fl
91.0
91.1
0.11
151
1437
(3035941) MCH [Entitic mass]
151
1464
1.43
0.51
47.5
18.5
pg
30.1
30.3
0.81
151
1437
(3002256) Pathology report gross observation
20
155
1.33
0.49
1.5
1.2
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
151
1467
1.40
0.46
48.0
18.6
g/l
129.4
135.7
4.87
151
1438
(3045414) Leukocytes [Presence] in Urine
7
50
1.42
0.45
1.7
1.7
—
—
—
0
0
(40768443) Skin Pathology biopsy report
8
59
1.37
0.41
1.6
1.1
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
0
15
0.00
0.41
0.0
1.4
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
0
17
0.00
0.41
0.0
1.3
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
0
19
0.00
0.39
0.0
2.2
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
9
66
1.38
0.39
8.7
3.1
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
20
164
1.25
0.34
18.1
7.2
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
18
146
1.26
0.34
4.1
2.2
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
142
1385
1.20
0.27
29.6
11.5
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
15
124
1.23
0.25
1.5
1.4
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
5
40
1.26
0.22
9.6
3.9
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
0
12
0.00
0.21
0.0
3.8
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
9
113
0.78
0.20
1.2
1.3
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
16
186
0.85
0.20
1.6
1.4
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
5
65
0.76
0.17
1.0
1.8
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
11
125
0.87
0.10
2.2
1.6
—
—
—
0
0
(4010399)
9
102
0.88
0.06
1.4
1.4
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
34
338
1.01
0.00
3.6
4.3
%
21.9
21.7
0.02
12
153
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
0
8
0.00
0.00
0.0
2.3
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
0
8
0.00
0.00
0.0
1.3
—
6.3
—
0
8
(3051651) Icteric interference index of Serum or Plasma
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.8
—
0.9
—
0
8
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
127.9
—
0
6
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
2.7
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
7
0.00
0.00
0.0
1.1
—
8.9
—
0
7
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
0
7
0.00
0.00
0.0
3.1
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.8
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: AB1_SEPSIS_PARAS_IMPL – Implicit parasitic Sepsis
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).